Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02119312 · ClinicalTrials.gov registry record
Malaria Clinical Trials Center General Screening
A clinical trial of Malaria, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- 2,101
- Enrollment target
- 1
- Study location
NCT02119312: Completed study of Malaria, sponsored by Fred Hutchinson Cancer Center.
NCT02119312 is a study of Malaria that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 2,101 participants, above the 180-participant average among 27 other Malaria trials with a reported enrollment target (1067% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02119312, a study of Malaria, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- 2,101 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify and screen potential subjects for preliminary eligibility to participate in a malaria related clinical trial conducted at the Seattle Malaria Clinical Trials Center (Seattle MCTC) or one of our partnering sites.
Primary Outcome
See inclusion/exclusion criteria.
Conditions Studied
Study Locations (1)
Washington
- Fred Hutchinson Cancer Research Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,101 participants |
| Start Date | 2010-06 |
| Est. Completion | 2020-09-01 |
What the finished NCT02119312 record still lists
NCT02119312 is an observational study that tracks outcomes without assigning an intervention. Its 2,101 participants enrollment target places it among the larger protocols in the corpus, above the 180-participant average among 27 other Malaria trials with a reported enrollment target (1067% higher).
The record links to 1 condition, with Malaria appearing as the primary indexed condition, and to 0 interventions.
NCT02119312 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT02119312 about?
NCT02119312 is a clinical study titled "Malaria Clinical Trials Center General Screening". The purpose of this study is to identify and screen potential subjects for preliminary eligibility to participate in a malaria related clinical trial conducted at the Seattle Malaria Clinical Trials Center (Seattle MCTC) or one of our partnering sites.
What is the current status of trial NCT02119312?
This trial is currently completed. The enrollment target is 2,101 participants. The study started on 2010-06. Estimated completion is 2020-09-01.
What conditions does trial NCT02119312 study?
This clinical trial studies the following conditions: Malaria.
Who is sponsoring clinical trial NCT02119312?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02119312 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malaria
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02119312's enrollment target sits among peer trials
2,101 1st of 27 higher than 27 of 27 other Malaria trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Malaria trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge
RECRUITING
-
Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants
RECRUITING
-
Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection
RECRUITING
-
A Study of Oral E1018 in Healthy Adult Participants
RECRUITING · Phase 1
-
Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Challenge Agent and Evaluate Transmission in Mosquito Feeding Assays
RECRUITING · Phase 1
-
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04649242 · 2,100 participants · Phase 3
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- NCT05206331 · 2,100 participants · Phase 4
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study
- NCT05270499 · 2,100 participants
Aveir VR Real-World Evidence Post-Approval Study
- NCT06324981 · 2,100 participants · NA
Using AI Text Messaging to Improve AHA's Life's Essential 8 Health Behaviors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia